CD19, CD20, and CD11c expression was not changed in AA+ progressors, while CD19 and CD20 expression was significantly elevated in peripheral blood cells of T1D patients vs. AA- FDRs (Figures 7B–D). Here, ITGAX is linked to type 1 diabetes mellitus.